Vertex Pharmaceuticals Inc / Ma

Capital Group Private Client Services, Inc. VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

23,852

Value ($000)

10,814

Weight

0.2%

2021 Q3 - 2025 Q4 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	10,814	0.2%	23,852	12/31/2025
2025 Q3	11/13/2025	9,742	0.2%	24,874	9/30/2025
2025 Q2	8/13/2025	46,540	0.4%	104,537	6/30/2025
2025 Q1	5/12/2025	12,427	0.1%	25,632	3/31/2025
2022 Q1	5/19/2022	14,934	0.2%	57,226	3/31/2022
2021 Q4	2/14/2022	12,554	0.1%	57,166	12/31/2021
2021 Q3	11/15/2021	11,271	0.1%	62,137	9/30/2021